“Rising Adoption of Point-of-Care (PoC) Microfluidic Devices”
- A growing trend in the microfluidics market is the increased use of PoC devices enabled by microfluidic technology for rapid diagnostics, particularly in resource-limited and remote settings. These compact and cost-effective devices offer real-time analysis with minimal sample volumes
- PoC microfluidic devices are being increasingly adopted in areas such as infectious disease testing, diabetes monitoring, and cardiac marker detection due to their portability, speed, and user-friendliness
- This trend aligns with the global push for decentralizing healthcare and delivering faster, patient-centric diagnostic solutions
- For instance, in 2024, Abionic SA launched a PoC microfluidic platform for sepsis risk assessment, enabling critical early detection within five minutes at the bedside
- The growing adoption of PoC devices is transforming diagnostic protocols, enabling faster treatment decisions and expanding microfluidics into primary care and emergency response settings
